Navigation Links
Syngenta Opens Unique $72 Million Advanced Crop Lab


•    First of its kind research facility

  •     Green Globes Certified for sustainability
  •     New facility will help solve crop stresses of drought and insect pressures

Syngenta unveiled its new crop research facility during a grand opening celebration today at the company’s RTP Innovation Center. The first of its kind, $72 million Advanced Crop Lab allows company researchers to simulate any agricultural climate and precisely measure plant inputs – the key to helping farmers grow more food from fewer resources.

“Our new Advanced Crop Lab allows us to bring together components of all research where we can create environments for multiple crops from multiple regions — simultaneously,” said Michiel van Lookeren Campagne, head of biotechnology for Syngenta. “Individual controls of temperature, light and carbon dioxide levels, as well as humidity control in many growth chambers, provide tailored environments that allow our talented researchers to work on specific grower challenges. In addition to innovative facilities, being in RTP, we have access to some of the greatest scientific minds to help farmers grow more from less.”

Housing 30 climate-controlled growth environments in all-glass greenhouses, Syngenta can simulate conditions from Iowa in one room and from Africa right next to it. This flexibility allows company researchers to focus on developing agricultural traits that optimize crop yields, use resources efficiently and resist various stresses that farmers face every day across the globe.

During the grand opening, North Carolina Governor Pat McCrory, North Carolina Agriculture Commissioner Steve Troxler, U.S. Senator Kay Hagan, growers and many others toured the new plant research facility.

“Syngenta invests more than $1.25 billion annually to directly focus on solving challenges for farmers. As we consider global food security, the research conducted in our new crop lab will be essential to meet that demand,” said Vern Hawkins, Syngenta North America region director.

Design elements of the new facility include insulated glass walls that provide a virtually shadowless indoor environment, a liquid “fertigation” system to feed and water the plants and an automated roof-washing system. The building is Green Globes Certified, which recognizes the company’s sustainable construction processes. In constructing the new facility, Syngenta reclaimed a former industrial site and recycled more than 85 percent of those materials.

The 136,000-square-foot facility is located within the 50-acre Syngenta RTP Innovation Center. Construction began in 2011 and was performed by nearly 300 local contractors, requiring roughly 500,000 man-hours to complete. Syngenta added 15 highly-skilled jobs to its existing RTP workforce.

For an RTP Innovation Center media kit, including speaker biographies, photos for media use and more, please visit:

Twitter @SyngentaBiotech

About Syngenta

Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers, we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us, please go to

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties including the “Risk Factors” in our Annual Report on Form 20-F. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract thereof.

The Syngenta logo is a registered trademark of a Syngenta Group Company.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Syngenta and Devgen enter insect control research partnership
2. Syngenta to acquire Pasteuria Bioscience
3. Pasteuria Bioscience to be Acquired by Syngenta
4. Syngenta Secures EU Approval For Next Generation Fungicide
5. Syngenta divests US flowers distribution and brokerage
6. Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development
7. Syngenta Licenses Plant Sensory Systems' Technology
8. Bayer CropScience and Syngenta Submit Herbicide-tolerance Soybean Trait for Approval in Various Countries
9. Syngenta and Bayer CropScience Propose a Comprehensive Action Plan to Help Unlock EU Stalemate on Bee Health
10. Syngenta Holds Annual General Meeting
11. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
Post Your Comments:
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):